Effects of exercise and consumption of Purslane seeds on osteoporosis

A clinical trial of a period of resistance training with consumption of Portulace oleraceal supplement (applied to three groups including only exercise, only supplement and exercise-supplement and their comparison with the control group) on bone factors osteoprotegerin and nuclear factor kappa B in women with diabetes type II

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015051717249N4

Enrollment

Registered

2015-06-03

Start date

2013-11-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis. Postmenopausal osteoporosis

Interventions

Intervention 1: Exercise group did resistance exercise with 40 to 50 percent One-repetition maximum by rubber band for 8 weeks, 3 sessions per week and 60 minutes per session. Intervention 2: Suppleme

Exercise group did resistance exercise with 40 to 50 percent One-repetition maximum by rubber band for 8 weeks, 3 sessions per week and 60 minutes per session

Supplement group were consumed daily 7.5 g Purslane seed powder (2.5 g with lunch mile and 5 g with diner mile) mixed with yogurt for 8 weeks.

Exercise- supplement group were consumed daily 7.5 g Purslane seed powder (2.5 g with lunch mile and 5 g with diner mile) mixed with yogurt for 8 weeks and also, did resistance exercise with 40 to 50

The control group did not participate in any stages of study.

Eligibility

Sex/Gender

Female

Age

44 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Not participating in regular physical activity during the last 6 months, Type 2 diabetic patients over 44 years. Exclusion criteria: History of cardiovascular disease, Smoking, Drug therapy (any drugs except Metformin) and if participant is healthy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Osteoprotegerin. Timepoint: Before and 8 weeks after intervention. Method of measurement: ELISA method.;Nuclear factor kappa B. Timepoint: Before and 8 weeks after intervention. Method of measurement: ELISA method.	—

Secondary

Measure	Time frame
Body weight. Timepoint: Before and 8 weeks after intervention. Method of measurement: Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParvin Farzanegi

Islamic Azad University, Sari Branch

parvin.farzanegi@gmail.com+98 113305334

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026